HORSHAM, Pa., June 1 /PRNewswire/ -- Centocor Ortho Biotech Inc. today announced that it has acquired RespiVert Ltd., a privately held drug discovery company focused on developing small-molecule, inhaled therapies for the treatment of pulmonary diseases.

NEW YORK, Nov. 16 /PRNewswire/ -- The Nielsen Company, a leading global information and media company and the CLIO Awards, one of the world's most recognized international advertising and design competitions, today announced the winners of the first-ever CLIO Healthcare Awards in all categories.

HORSHAM, Pa., May 28 /PRNewswire/ -- Centocor Ortho Biotech Products, L.P. today announced that data related to several compounds will be presented at the 45th American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando, Fla., from May 29 to June 2, 2009.

BALTIMORE, Jan. 6 /PRNewswire/ -- FASgen, Inc. is pleased to announce that it has entered into a research and license agreement with Centocor, Inc. This agreement will give Centocor, Inc.

- The first approval for an antibody generated from Medarex's UltiMAb(R) technology platform - PRINCETON, N.J., Dec. 15 /PRNewswire-FirstCall/ -- Medarex, Inc.